|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
19 February 2015 |
|
Main ID: |
NCT01397773 |
|
Date of registration:
|
18/07/2011 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Pentraxin-3 in Chronic Renal Failure
|
|
Scientific title:
|
The Role Pentraxin-3 in the Inflammatory Process in Chronic Renal Failure, and the Association With Other Inflammatory Parameters |
|
Date of first enrolment:
|
April 2010 |
|
Target sample size:
|
85 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT01397773 |
|
Study type:
|
Observational |
|
Study design:
|
Observational Model: Case Control, Time Perspective: Cross-Sectional
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Turkey
| | | | | | | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- To give informed consent
- Hemodialysis or peritoneal dialysis for more than 3 months
- Creatinin clearance less than 30 ml/min for the pre-dialysis group
Exclusion Criteria:
- Not to give informed concent
- Active infection within the last 3 months
- Known chronic inflammatory disease
Age minimum:
16 Years
Age maximum:
80 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Chronic Kidney Disease
|
|
Inflammation
|
|
Primary Outcome(s)
|
|
Pentraxin-3 level
[Time Frame: Five months]
|
|
Secondary Outcome(s)
|
|
Carotis intima media thickness
[Time Frame: Five months]
|
|
Secondary ID(s)
|
|
PTX-HASEKI
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|